{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-437774","form_type":"8-K","ticker":"ENTA","cik":"0001177648","company_name":"ENANTA PHARMACEUTICALS INC","filed_at":"2026-10-29T20:05:15+00:00","discovered_at":"2026-10-29T20:06:00.232096+00:00","generated_at":"2026-10-29T20:06:17.486549+00:00","sec_items":["8.01"],"event_type":"litigation","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"UPC invalidates Enanta's EP 4 051 265 patent; Paxlovid infringement action against Pfizer dismissed","bullets":["Unified Patent Court ruled on October 29, 2026 that European Patent No. EP 4 051 265 is invalid, and that Enanta's infringement action was unfounded in light of that holding.","Enanta had sued Pfizer and subsidiaries in the UPC over Pfizer's manufacture, use and sale of Paxlovid (nirmatrelvir/ritonavir tablets) across the 18 EU member states participating in the UPC.","Pfizer counterclaimed for revocation of the '265 Patent; a hearing on both the infringement action and the revocation counterclaim was held September 29, 2026.","The decision removes Enanta's asserted European patent claims against Paxlovid in the UPC jurisdiction, with no injunction or damages awarded to Enanta."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-437774","json":"https://secwatch.observer/filing/0001193125-26-437774.json","markdown":"https://secwatch.observer/filing/0001193125-26-437774.md","text":"https://secwatch.observer/filing/0001193125-26-437774.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1177648/000119312526437774/0001193125-26-437774-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1177648/000119312526437774/enta-20261029.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-10-29T20:06:17.486549+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}